Your browser doesn't support javascript.
loading
Validity of hospital ICD-10-GM codes to identify anaphylaxis.
de Sordi, Dominik; Kappen, Sanny; Otto-Sobotka, Fabian; Kulschewski, Anke; Weyland, Andreas; Gutierrez, Lia; Fortuny, Joan; Reinold, Jonas; Schink, Tania; Timmer, Antje.
Afiliación
  • de Sordi D; Division of Epidemiology and Biometry, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
  • Kappen S; Division of Epidemiology and Biometry, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
  • Otto-Sobotka F; Division of Epidemiology and Biometry, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
  • Kulschewski A; Section for Kidney Disease and Hypertension, Clinic of Internal Medicine, Klinikum Oldenburg, Oldenburg, Germany.
  • Weyland A; Department of Anaesthesiology, Intensive Care Medicine, Emergency Medicine, Pain Therapy, Klinikum Oldenburg, Oldenburg, Germany.
  • Gutierrez L; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.
  • Fortuny J; Pharmacoepidemiology and Risk Management, RTI Health Solutions, Barcelona, Spain.
  • Reinold J; Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Schink T; Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Timmer A; Division of Epidemiology and Biometry, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
Pharmacoepidemiol Drug Saf ; 30(12): 1643-1652, 2021 12.
Article en En | MEDLINE | ID: mdl-34418227
PURPOSE: Anaphylaxis (ANA) is an important adverse drug reaction. We examined positive predictive values (PPV) and other test characteristics of ICD-10-GM code algorithms for detecting ANA as used in a multinational safety study (PASS). METHODS: We performed a cross-sectional study on routine data from a German academic hospital (2004-2019, age ≥ 18). Chart review was used for case verification. Potential cases were identified from the hospital administration system. The main outcome required at least one of the following: any type of specific in-hospital code (T78.2, T88.6, and T80.5) OR specific outpatient code in combination with a symptom code OR in-hospital non-specific code (T78.4, T88.7, and Y57.9) in combination with two symptom codes. PPV were calculated with 95% confidence interval. Sensitivity analyses modified type of codes, unit of analysis, verification criteria and time period. The most specific algorithm used only primary codes for ANA (numbers added in brackets). RESULTS: Four hundred and sixteen eligible cases were evaluated, and 78 (37) potential ANA cases were identified. PPV were 62.8% (95% CI 51.1-73.5) (main) and 77.4% (58.9-90.4) (most specific). PPV from all modifications ranged from 12.9% to 80.6%. The sensitivity of the main algorithm was 66.2%, specificity 91.5%, and negative predictive value 92.6%. Corresponding figures for the most specific algorithm were 32.4%, 98.0%, and 87.0%. CONCLUSIONS: The PPV of the main algorithm seems of acceptable validity for use in comparative safety research but will underestimate absolute risks by about a third. Restriction to primary discharge codes markedly improves PPV to the expense of reducing sensitivity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Anafilaxia Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_sistemas_informacao_saude Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Anafilaxia Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Alemania
...